Skip to main content
ENLV
NASDAQ Life Sciences

Enlivex's Primary Digital Treasury Asset, RAIN Token, Listed on KuCoin Exchange

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.817
Mkt Cap
$195.151M
52W Low
$0.66
52W High
$2.1
52W Position info
24% above low
Off High info
61% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

ENLV sits 24% above its 52-week low of $0.66 on light trading volume (0.1× avg).

Summary

Enlivex announced the listing of its primary digital treasury asset, the RAIN token, on the KuCoin cryptocurrency exchange, aiming to boost liquidity and market access.


Key Events · Financing and Capital Events · ENLV

  • RAIN Token Listed on KuCoin

    Enlivex's primary digital treasury asset, the RAIN token, commenced trading on the KuCoin cryptocurrency exchange effective January 6, 2026.

  • Expanded Market Access and Liquidity

    The listing on KuCoin, a major global cryptocurrency exchange, is expected to expand global market access and secondary liquidity for the RAIN token.

  • Supports Digital Asset Treasury Strategy

    This development is a meaningful milestone for Enlivex's digital asset treasury strategy, which is centered on the acquisition and positioning of RAIN tokens.


Analysis · ENLV · Life Sciences

Enlivex Therapeutics, a life sciences company, announced the listing of its primary digital treasury asset, the RAIN token, on the KuCoin cryptocurrency exchange. This move is expected to significantly expand market access and secondary liquidity for the RAIN token, which is central to the company's digital asset treasury strategy. While not directly related to its core drug development business, this development enhances the financial flexibility and potential value of a key company asset.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ENLV was trading at $0.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $195.2M. The 52-week trading range was $0.66 to $2.10. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ENLV - Latest Insights

ENLV
Sep 29, 2026, 5:10 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4956
Real-time Price: $0.501 info
Change: +$0.0054 (+1%) info
Market Cap: $8.792M info
ENLV
Sep 25, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.5938
Real-time Price: $0.501 info
Change: -$0.0928 (-16%) info
Market Cap: $8.792M info
ENLV
Sep 22, 2026, 8:02 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7005
Real-time Price: $0.501 info
Change: -$0.1995 (-28%) info
Market Cap: $8.792M info
ENLV
Aug 11, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.92
Real-time Price: $0.501 info
Change: -$1.42 (-74%) info
Market Cap: $8.792M info
ENLV
Aug 06, 2026, 4:43 PM EDT
Filing Type: F-3
Importance Score:
7
Price at Filing: $1.94
Real-time Price: $0.501 info
Change: -$1.44 (-74%) info
Market Cap: $8.792M info